Marsh is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital... Show more
Marsh & McLennan Companies, Inc. operates primarily through two segments: Risk and Insurance Services, which includes insurance broking, risk management, and reinsurance solutions via brands such as Marsh and Guy Carpenter; and Consulting, encompassing health, wealth, career advice, and management consulting through Mercer and Oliver Wyman. This dual structure provides diversified revenue streams with approximately half generated outside the United States. Competitive advantages stem from global scale, deep client relationships across industries, and integrated analytics capabilities that differentiate the firm in a fragmented market. Medium-term positioning benefits from a focus on high-value advisory services rather than commoditized products, though structural risks include intense competition from both traditional brokers and technology-enabled entrants seeking to disrupt advisory models.
Scheduled earnings releases represent a primary catalyst, as they often include forward-looking commentary on segment performance and any revisions to strategic priorities. Product or service launches in areas such as advanced risk modeling and digital consulting platforms could drive client adoption and revenue diversification. Regulatory decisions affecting insurance markets or data privacy may create opportunities for specialized advisory work. Strategic partnerships or capital allocation moves, including potential share repurchases or dividend adjustments, often influence investor perceptions of financial flexibility. Analyst rating changes and price-target revisions provide additional sentiment signals; consensus data from reputable sources can highlight whether expectations are trending more optimistic or cautious over time. Each of these developments has the potential to affect how the market values the company's ability to navigate complex risk environments.
The professional services sector in risk and consulting is closely tied to broader economic conditions. Interest rate fluctuations can impact insurance premium cycles and client budgets for advisory engagements. Inflation trends may drive demand for cost-optimization consulting while affecting reinsurance pricing. Geopolitical developments and technology adoption trends, particularly in cybersecurity and climate-related risks, directly align with the company's core offerings in risk mitigation and strategic planning. Regulatory climate changes, such as evolving capital requirements for insurers or workplace compliance standards, could expand the addressable market for consulting services. These forces connect to the business model by influencing both the volume of insurance placements and the complexity of human capital and management challenges clients face.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. Trend Prediction Engine
Looking to 2026 and beyond, market expansion opportunities may arise from growing demand for specialized risk solutions amid ongoing global uncertainties. Cost structure evolution through technology integration could support margin sustainability in both segments. Technology transitions, including greater use of data analytics and artificial intelligence in advisory work, represent both an opportunity and a competitive necessity. Potential regulatory developments in insurance and consulting could shape service offerings, while capital allocation priorities such as investments in talent or acquisitions may influence long-term growth trajectories. Consensus analyst expectations, where available, often incorporate assumptions about sustained demand for risk management expertise and the resilience of consulting revenues, providing a framework for evaluating how market assumptions align with the company's strategic direction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MRSH has been closely correlated with AON. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if MRSH jumps, then AON could also see price increases.
| Ticker / NAME | Correlation To MRSH | 1D Price Change % | ||
|---|---|---|---|---|
| MRSH | 100% | -0.95% | ||
| AON - MRSH | 81% Closely correlated | -1.64% | ||
| AJG - MRSH | 77% Closely correlated | -2.75% | ||
| BRO - MRSH | 75% Closely correlated | -0.66% | ||
| WTW - MRSH | 63% Loosely correlated | -0.04% | ||
| ERIE - MRSH | 53% Loosely correlated | +3.58% | ||
More | ||||
| Ticker / NAME | Correlation To MRSH | 1D Price Change % |
|---|---|---|
| MRSH | 100% | -0.95% |
| MRSH (5 stocks) | 88% Closely correlated | -1.21% |
| Insurance Brokers/Services (20 stocks) | 84% Closely correlated | +0.38% |
| Insurance (118 stocks) | 66% Closely correlated | -0.24% |
MRSH saw its Momentum Indicator move above the 0 level on July 24, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for MRSH just turned positive on July 28, 2026. Looking at past instances where MRSH's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
MRSH moved above its 50-day moving average on June 26, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MRSH crossed bullishly above the 50-day moving average on July 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 265 cases where MRSH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MRSH moved out of overbought territory on July 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MRSH broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.963) is normal, around the industry mean (6.393). P/E Ratio (23.161) is within average values for comparable stocks, (36.178). Projected Growth (PEG Ratio) (1.824) is also within normal values, averaging (1.743). Dividend Yield (0.020) settles around the average of (0.014) among similar stocks. P/S Ratio (3.316) is also within normal values, averaging (3.159).